Back to Trials
NCT04310241Recruiting

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

The Cleveland Clinic

Start Date

2/21/2020

Completion Date

3/12/2027

Summary

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

Detailed Description

To examine the response of therapy on visual functions in amblyopic and strabismic participants. The following visual functions will be measured prior to treatment. Eye movements, contrast sensitivity, grating acuity, visual acuity, vernier acuity, binocular visual functions, reading and visual scanning will be measured. The testing will comprise of one or more of the above paradigms depending on participant's cooperation and understanding as majority of the study participants will be children. The above measurements will be repeated during amblyopia therapy ( which comprises of glasses, patching and/or atropine eye drops) and at the completion of treatment. For participants with strabismus requiring strabismus surgery the measurements will be repeated after strabismus surgery.

Eligibility Criteria

Age Range: No minimum to 90 years

Inclusion Criteria: * History of amblyopia or presence of amblyogenic risk factors. Exclusion Criteria: * History of neurologic disorders

Interventions

BEHAVIORAL

Patching therapy, Glasses

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

AmblyopiaStrabismus

Locations

Cleveland Clinic

Cleveland, Ohio 44195

United States